Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

pVACtools v6: A comprehensive suite for neoantigen prediction, visualization, and therapy design.

ArXiv·2026

Same author

Individualised N-terminal Pro-B-type Natriuretic Peptide Thresholds for the Diagnosis of Heart Failure: A Proof-of-Concept Study.

Cureus·2026

Same author

Long-read cDNA sequencing reveals novel isoforms and spliceosome-mutant-enriched transcripts in AML and MDS.

bioRxiv : the preprint server for biology·2026

Same author

Cardio-oncology research prioritisation in the United Kingdom: national surveys of health care professionals, patients and carers.

Cardio-oncology (London, England)·2026

Same author

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.

Nature cancer·2026

Same author

NAD+ augmentation by nicotinamide riboside engages SLIT2/ROBO1 signaling to attenuate Th17 inflammation in psoriasis.

JCI insight·2026

Same journal

Multi-omics profiles of sex hormone-binding globulin are associated with subclinical atherosclerosis in men with HIV.

Genome medicine·2026

Same journal

Multi-modal data integration reveals functionally credible predictive biomarkers in ovarian cancer.

Genome medicine·2026

Same journal

Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNK.

Genome medicine·2026

Same journal

Identification and functional characterization of regulatory variants in DPP9 associated with COVID-19 severity.

Genome medicine·2026

Same journal

De novo variants in NPTN cause a neurodevelopmental disorder with autism and neuroplastin-PMCA hypofunction.

Genome medicine·2026

Same journal

Dual functional genomics reveals a broad and convergent landscape of asciminib resistance in BCR::ABL1.

Genome medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 7, 2025

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

pVACview: an interactive visualization tool for efficient neoantigen prioritization and selection.

Huiming Xia^1,2, My H Hoang¹, Evelyn Schmidt¹

¹Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Genome Medicine

|November 14, 2024

Summary

This summary is machine-generated.

pVACview is a new tool that helps researchers select cancer neoantigens for personalized vaccines. It simplifies complex data, improving the efficiency and accuracy of neoantigen prioritization for cancer therapy development.

Keywords:

Cancer immunotherapy Data visualization Neoantigen Pipeline Prioritization Vaccine design

More Related Videos

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

Related Experiment Videos

Last Updated: Jun 7, 2025

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

Area of Science:

Oncology
Immunology
Bioinformatics

Background:

Neoantigen-targeting therapies, including personalized cancer vaccines, show promise when combined with checkpoint blockade therapy.
Accurate neoantigen identification and prioritization are critical for clinical trial design, treatment response prediction, and understanding resistance mechanisms.
Computational prediction of neoantigens is possible with advanced sequencing, but complexities in data analysis hinder effective selection.

Purpose of the Study:

To develop an interactive tool, pVACview, that aids in the prioritization and selection of neoantigen candidates for personalized neoantigen therapies.
To address the challenge of navigating complex neoantigen prediction data and facilitate downstream applications.

Main Methods:

Development of pVACview, an interactive and user-friendly software tool.
Implementation of an interface for uploading, exploring, selecting, and exporting neoantigen candidates.
Visualization of neoantigen candidates at multiple levels: variant, transcript, peptide, and algorithm prediction.

Main Results:

pVACview provides the first interactive platform for neoantigen candidate prioritization.
The tool offers a user-friendly interface for managing neoantigen data.
Enables detailed visualization of neoantigen characteristics and prediction data.

Conclusions:

pVACview enhances the efficiency and accuracy of neoantigen candidate analysis and prioritization in research and translational settings.
The software is available as part of pVACtools and as an online server for broader accessibility.